|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1991-7-29
|
|
pubmed:abstractText |
To determine if a 6-month course of therapy with IMREG-1, a leukocyte-derived immunomodulator, slows disease progression in patients with AIDS-related complex.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
84-91
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1676251-AIDS-Related Complex,
pubmed-meshheading:1676251-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:1676251-Adult,
pubmed-meshheading:1676251-CD4-Positive T-Lymphocytes,
pubmed-meshheading:1676251-Double-Blind Method,
pubmed-meshheading:1676251-Female,
pubmed-meshheading:1676251-Humans,
pubmed-meshheading:1676251-Leukocyte Count,
pubmed-meshheading:1676251-Lymphokines,
pubmed-meshheading:1676251-Male,
pubmed-meshheading:1676251-Middle Aged,
pubmed-meshheading:1676251-Probability,
pubmed-meshheading:1676251-Proportional Hazards Models,
pubmed-meshheading:1676251-Statistics as Topic
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial.
|
|
pubmed:affiliation |
Imreg, Inc., New Orleans, Louisiana.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
